H. R. 1843 proposes amendments to the Federal Food, Drug, and Cosmetic Act focused on increasing transparency in the applications for generic drugs. The bill requires the Secretary of Health and Human Services to inform drug manufacturers if their generic product is the same as the original...
Simple Explanation
H. R. 1843 wants to make it easier for people to know if a copy of a medicine is exactly like the original one, and it asks the people in charge to share all needed information and listen to what everyone has to say before making any big decisions.